Provided by Tiger Trade Technology Pte. Ltd.

DexCom

68.43
-1.6700-2.38%
Pre-market: 68.430.00000.00%06:32 EST
Volume:4.56M
Turnover:310.56M
Market Cap:26.69B
PE:38.08
High:69.84
Open:69.33
Low:67.30
Close:70.10
52wk High:93.25
52wk Low:54.11
Shares:390.02M
Float Shares:389.51M
Volume Ratio:1.19
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.80
EPS(LYR):1.46
ROE:30.63%
ROA:7.02%
PB:9.79
PE(LYR):46.74

Loading ...

RBC Capital Reaffirms Their Buy Rating on Dexcom (DXCM)

TIPRANKS
·
10 hours ago

DexCom Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
14 hours ago

BRIEF-Dexcom Enters Next Era Of Continued Innovation With Jake Leach As Chief Executive Officer

Reuters
·
Jan 07

DexCom Names Jake Leach as President and CEO

Reuters
·
Jan 07

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

THOMSON REUTERS
·
Jan 07

DexCom Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jan 06

Reassessing DexCom (DXCM): Is the Market Underestimating Its Valuation After a Year of Weaker Share Price Performance?

Simply Wall St.
·
Jan 05

It’s Earnings Warning Season. How to Profit From Others’ Misery

Dow Jones
·
Jan 01

DexCom Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jan 01

BRIEF-FDA Says Dexcom Issues Correction For Dexcom G6 And G6 Pro Software

Reuters
·
Dec 30, 2025

FDA- Dexcom Issues Correction for Dexcom G6 and G6 Pro Software

THOMSON REUTERS
·
Dec 30, 2025

DexCom Faces Class Action Lawsuit Alleging Securities Fraud

Reuters
·
Dec 23, 2025

DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 23, 2025

DexCom Awards New CEO Jacob Leach $1.15 Million Salary and $15 Million Equity Package

Reuters
·
Dec 23, 2025

BUZZ - Nasdaq top and bottom performing stocks at about 11:13 a.m. EST on 2025-12-22

Reuters
·
Dec 23, 2025

DexCom Faces Investor Class Action Over Alleged Securities Fraud

Reuters
·
Dec 20, 2025

3 Stocks Estimated To Be Undervalued By Up To 48.3%

Simply Wall St.
·
Dec 20, 2025

Dexcom (DXCM): Valuation Check After Launch of Dexcom Academy for EMEA Healthcare Professionals

Simply Wall St.
·
Dec 18, 2025

DexCom Faces Class Action Lawsuit Over Alleged False Statements on Glucose Monitor Safety

Reuters
·
Dec 17, 2025

Leerink Partners Adjusts Price Target on DexCom to $92 From $81, Maintains Outperform Rating

MT Newswires Live
·
Dec 16, 2025